Every week, Zacks stock strategist Tracey Ryniec hosts the Zacks Market Edge Podcast, and is joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
Tracey has covered the marijuana industry over the years as it has evolved from an investment option with slim pickings to one that offers growing legitimacy and profitability.
Back in early 2017, Tracey got together with David Bartosiak, Editor of Zacks Surprise Trader, Momentum Trader and Blockchain Innovators newsletters, to discuss how investors could get rich off marijuana stocks. Just two short years ago there were only a few viable options to play the marijuana trade.
Tracey was joined by David once again in mid-2018, and a lot had changed throughout the industry since the first time they talked. Demand was growing higher for post stocks, and several marijuana ETFs launched or had plans in the works to launch. Additionally, some big-name beverage companies began making key investments in marijuana, like Molson Coors (TAP - Free Report) and Constellation Brands (STZ - Free Report) .
Now, in 2019, the marijuana industry looks completely different, and Tracey was joined by David Borun, Zacks Stock Strategist and editor of the upcoming Marijuana Innovators newsletter, to talk about it all.
Legalization was a big winner in the recent U.S. midterm elections, and we can’t forget Canada becoming the second nation in the world to officially legalize recreational pot last October. From big Canadian firms like Tilray (TLRY - Free Report) making their debut on the major U.S. exchanges to companies like Altria Group (MO - Free Report) getting into the cannabis game, 2019 could be a huge year for marijuana.
Zacks 2019 Marijuana Investors’ Summit: In addition to the companies you learned about above, we invite you to learn more about investing in pot stocks. On Tuesday, February 26, our team of experts will reveal what we believe is the single best way to make money from legal marijuana. Register Now for Free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Every week, Zacks stock strategist Tracey Ryniec hosts the Zacks Market Edge Podcast, and is joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
Tracey has covered the marijuana industry over the years as it has evolved from an investment option with slim pickings to one that offers growing legitimacy and profitability.
Back in early 2017, Tracey got together with David Bartosiak, Editor of Zacks Surprise Trader, Momentum Trader and Blockchain Innovators newsletters, to discuss how investors could get rich off marijuana stocks. Just two short years ago there were only a few viable options to play the marijuana trade.
Tracey was joined by David once again in mid-2018, and a lot had changed throughout the industry since the first time they talked. Demand was growing higher for post stocks, and several marijuana ETFs launched or had plans in the works to launch. Additionally, some big-name beverage companies began making key investments in marijuana, like Molson Coors (TAP - Free Report) and Constellation Brands (STZ - Free Report) .
Now, in 2019, the marijuana industry looks completely different, and Tracey was joined by David Borun, Zacks Stock Strategist and editor of the upcoming Marijuana Innovators newsletter, to talk about it all.
Legalization was a big winner in the recent U.S. midterm elections, and we can’t forget Canada becoming the second nation in the world to officially legalize recreational pot last October. From big Canadian firms like Tilray (TLRY - Free Report) making their debut on the major U.S. exchanges to companies like Altria Group (MO - Free Report) getting into the cannabis game, 2019 could be a huge year for marijuana.
Zacks 2019 Marijuana Investors’ Summit: In addition to the companies you learned about above, we invite you to learn more about investing in pot stocks. On Tuesday, February 26, our team of experts will reveal what we believe is the single best way to make money from legal marijuana. Register Now for Free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MO - FREE
Get the latest research report on TAP - FREE
Get the latest research report on STZ - FREE
Get the latest research report on TLRY - FREE